http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104418952-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 |
| filingDate | 2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104418952-B |
| titleOfInvention | A kind of anti-ErbB bispecific antibody for being used to treat breast cancer |
| abstract | Bispecific antibody the invention belongs to biological technical field there is provided a class for treating breast cancer.One class is used for the anti-ErbB bispecific antibody for treating breast cancer, its antigen binding domain is made up of the antigen binding domain of Trastuzumab antibody and Pertuzumab antibody, and the present invention builds the bispecific antibody that a class targets ErbB2 molecule different epitopes using biotechnology.Present invention also offers the DNA sequence dna for encoding this antibody-like, the expression vector containing this DNA sequence dna and the host cell containing this expression vector.The class that the present invention is provided is used for the bispecific antibody for treating breast cancer, specific can be combined with the outer II areas of ErbB2 molecular cells and IV areas, and the effect with notable in vitro and in vivo anti-breast cancer. |
| priorityDate | 2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 634.